Evidence map›Paper›PMID 21318452›Full record

Trial reportEuropean archives of psychiatry and clinical neuroscience2011

The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study.

Yaser Tajalizadekhoob, Farshad Sharifi, Hossein Fakhrzadeh, Mojde Mirarefin, Maryam Ghaderpanahi, Zohre Badamchizade, Solaleh Azimipour

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European archives of psychiatry and clinical neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04210804 (A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder), which is not on this map. Cited by 27 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 9 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04210804 phase2completednot on this mapstarted 2014, after this paper: background citation

A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder

TypeinterventionalSponsorNational University of Ireland, Galway, IrelandRan2014 to 2018Enrolled80ConditionsBipolar DepressionArmsSmoothie 1g Eicosapentaneoic Acid (EPA) and 1g Docoshaexanoic Acid (DHA)
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 9 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Omega-3 fatty acids for depression in adults.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Pooled it
  4. Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology.International journal of molecular sciences · 2020
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression.The British journal of psychiatry : the journal of mental science · 2016
    Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Yaser TajalizadekhoobEndocrinology and Metabolism Research Center, Tehran University of Medical Sciences, 5th floor, Dr Shareeati Hospital, North Karegar Avenue, Tehran, Iran.
Farshad Sharifi
Hossein Fakhrzadeh
Mojde Mirarefin
Maryam Ghaderpanahi
Zohre Badamchizade
Solaleh Azimipour
Shariati Hospital · IRTehran University of Medical Sciences · IRSouthwestern Medical Center

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the rise in the social and economic costs of depression, new antidepressant medication with fewer side effects should be found. Several studies have shown that an association exists between ω-3 polyunsaturated fatty acids (ω-3 PUFAs) and depression. However, this association has not been clear enough in the elderly with mild to moderate depression. Sixty-six inhabitants of Kahrizak Charity Foundation participated in this double-blind, randomized, placebo-controlled study. Each participant was ≥ 65 years of age, had a Mini Mental State Exam of ≥ 22, and had scores ranging from 5 to 11 on the Geriatric Depression Scale-15 (GDS-15). During the 6 months, the drug group was treated daily with one gram of fish oil capsule containing 300 mg of both eicosapentaenoic acid and docosahexaenoic acid. No significant differences were noted between the groups in regard to level of education, use of antidepressant drugs, alcohol, tobacco use, history of chronic diseases, age, body mass index (BMI), high-sensitive C-reactive protein (hs-CRP), total cholesterol, and GDS-15 scores at baseline. After adjusting for cholesterol, BMI, and history of thyroid dysfunctions, a statistically significant difference was seen in GDS-15 scores between both groups. Furthermore, treatment with ω-3 PUFAs was clinically more effective in treating depression in comparison with the placebo. In this study, low-dose ω-3 PUFAs had some efficacy in the treatment of mild to moderate depression in elderly participants.

Indexed as

AgedAged, 80 and overAntidepressive AgentsDepressionDietDouble-Blind MethodDrug HypersensitivityFatty Acids, Omega-3FemaleFish OilsHumansMaleNeuropsychological TestsSample SizeSocioeconomic FactorsTreatment OutcomeAntidepressive AgentsFatty Acids, Omega-3Fish Oils

Identifiers

PMID21318452
OpenAlexW1982213477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.